Literature DB >> 28391028

LncRNA expression profile of ΔNp63α in cervical squamous cancers and its suppressive effects on LIF expression.

Lili Qian1, Fei Xu1, Xiaolin Wang2, Ming Jiang2, Juan Wang1, Weiguo Song1, Dabao Wu1, Zhen Shen1, Dingqing Feng3, Bin Ling3, Yong Cheng4, Weihua Xiao5, Ge Shan6, Ying Zhou7.   

Abstract

We aim to determine the lncRNA targets of ΔNp63α in cervical cancer and molecular programs in cancerous differentiation. Different profiles of the lncRNAs were assayed and validated in overexpressing p63 SiHa cells (SiHa/ΔNp63α) and the control cell lines (SiHa/pCon). ENST00000422259, ENST00000447565 (Lnc-LIF-AS) and ENST00000469965, together with their related antisense mRNA DPYD (dihydropyrimidine dehydrogenase, a pyrimidine catabolic pathway gene), LIF (leukemia inhibitor factor) and FLNC (filamin C) were all notably differentially expressed in both ΔNp63α overexpression cells and knockdown cells. Here, we illustrated that ΔNp63α can inhibit the levels of LIF mRNA by direct transcription regulation and decrease LIF mRNA stability by suppressing the expression of Lnc-LIF-AS. An inverse interaction of LIF and ΔNp63α expression was as well validated in clinical samples of cervical cancer, and high level of LIF in cervical cancers was related with poor patient survival. The decrease of ΔNp63α also attenuated the differentiation of cervical cancerous cells. Suggesting that ΔNp63α may be form a complex network in regulation cervical cancerous differentiation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cervical cancer; LIF; LncRNA; ΔNp63α

Mesh:

Substances:

Year:  2017        PMID: 28391028     DOI: 10.1016/j.cyto.2017.04.001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  ΔNp63α exerts antitumor functions in cervical squamous cell carcinoma.

Authors:  Ying Zhou; Hanyuan Liu; Juan Wang; Xiaolin Wang; Lili Qian; Fei Xu; Weiguo Song; Dabao Wu; Zhen Shen; Dingqing Feng; Bin Ling; Weihua Xiao; Ge Shan; Liang Chen
Journal:  Oncogene       Date:  2019-10-01       Impact factor: 9.867

2.  si-TP73-AS1 suppressed proliferation and increased the chemotherapeutic response of GC cells to cisplatin.

Authors:  Jianjun Peng
Journal:  Oncol Lett       Date:  2018-07-10       Impact factor: 2.967

3.  lncRNA FEZF1-AS1 regulates biological behaviors of cervical cancer by targeting miRNA-1254.

Authors:  Miao Liang; Yongkang Li; Tingting Dai; Cheng Chen
Journal:  Food Sci Nutr       Date:  2021-07-14       Impact factor: 2.863

Review 4.  Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer.

Authors:  Megan M Jorgensen; Pilar de la Puente
Journal:  Biomolecules       Date:  2022-01-27

5.  LINC00673 rs11655237 Polymorphism Is Associated With Increased Risk of Cervical Cancer in a Chinese Population.

Authors:  Yanhua Wang; Tianyou Luo
Journal:  Cancer Control       Date:  2018 Jan-Dec       Impact factor: 3.302

6.  Synergetic Effects of Intronic Mature miR-944 and ΔNp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line.

Authors:  Jungho Kim; Sunyoung Park; Yunhee Chang; Kwang Hwa Park; Hyeyoung Lee
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

7.  lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma.

Authors:  Hanyuan Liu; Chenchen Zhu; Zhihao Xu; Juan Wang; Lili Qian; Qingqing Zhou; Zhen Shen; Weidong Zhao; Weihua Xiao; Liang Chen; Ying Zhou
Journal:  Cancer Sci       Date:  2020-09-29       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.